Jiacheng Li

1.4k total citations
93 papers, 845 citations indexed

About

Jiacheng Li is a scholar working on Molecular Biology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Jiacheng Li has authored 93 papers receiving a total of 845 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 24 papers in Surgery and 19 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Jiacheng Li's work include RNA modifications and cancer (8 papers), Cancer Immunotherapy and Biomarkers (7 papers) and Ferroptosis and cancer prognosis (7 papers). Jiacheng Li is often cited by papers focused on RNA modifications and cancer (8 papers), Cancer Immunotherapy and Biomarkers (7 papers) and Ferroptosis and cancer prognosis (7 papers). Jiacheng Li collaborates with scholars based in China, Australia and United States. Jiacheng Li's co-authors include Shifeng Yang, Fang Han, Hao Yang, Peng Li, Yao Xiao, Tong Liu, Qing Song, Tingting Meng, Xiaoming Zou and Kejie Zhang and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and ACS Nano.

In The Last Decade

Jiacheng Li

78 papers receiving 831 citations

Peers

Jiacheng Li
Xin Miao United States
Chuan Liu China
Xinxin Ren China
Lianfeng Zhang China
Yidong Liu China
Li‐Yuan Bai Taiwan
Tomokazu Nagao Japan
Paul Wong United States
Mohammad Azhar Aziz Saudi Arabia
Xin Miao United States
Jiacheng Li
Citations per year, relative to Jiacheng Li Jiacheng Li (= 1×) peers Xin Miao

Countries citing papers authored by Jiacheng Li

Since Specialization
Citations

This map shows the geographic impact of Jiacheng Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiacheng Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiacheng Li more than expected).

Fields of papers citing papers by Jiacheng Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jiacheng Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiacheng Li. The network helps show where Jiacheng Li may publish in the future.

Co-authorship network of co-authors of Jiacheng Li

This figure shows the co-authorship network connecting the top 25 collaborators of Jiacheng Li. A scholar is included among the top collaborators of Jiacheng Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jiacheng Li. Jiacheng Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Jiacheng, Wei Lu, Lihong Lin, et al.. (2025). Trends in lower extremity peripheral arterial disease incidence since 1990 and forecasting future statistics using Global Burden of Disease 2021: a time-series analysis. Frontiers in Public Health. 13. 1521927–1521927. 1 indexed citations
2.
Li, Jiacheng, Jia Liu, Shifeng Yang, et al.. (2025). PD-L1 positive platelets mediate resistance to immune checkpoint inhibitors in patients with colorectal cancer. Cell Communication and Signaling. 23(1). 29–29. 4 indexed citations
3.
4.
Liu, Xin, et al.. (2025). Panax Notoginseng Saponins Inhibit Apoptosis and Alleviate Renal Ischemia–Reperfusion Injury Through the ROCK2/NF-κB Pathway. Molecular Biotechnology. 68(1). 223–234. 1 indexed citations
5.
6.
Lü, Mengmeng, Qi‐Wen Chen, Zhiyuan Bo, et al.. (2024). Systematic profiling of mitochondria-related transcriptome in tumorigenesis, prognosis, and tumor immune microenvironment of intrahepatic cholangiocarcinoma: a multi-center cohort study. Frontiers in Genetics. 15. 1430885–1430885. 4 indexed citations
7.
Bao, Wenming, Xiaozai Xie, Bo Chen, et al.. (2024). Liensinine inhibits progression of intrahepatic cholangiocarcinoma by regulating TGF‐β1 /P‐smad3 signaling through HIF‐1a. Molecular Carcinogenesis. 63(4). 772–784. 4 indexed citations
8.
Li, Jiacheng, Wei Lu, Lihong Lin, et al.. (2024). Comparison of clinical outcomes of drug-coated balloons angioplasty vs. plain old balloons angioplasty for peripheral arterial disease: an umbrella meta-analysis. Frontiers in Cardiovascular Medicine. 11. 1511268–1511268. 1 indexed citations
9.
Mao, Yicheng, Jiacheng Li, Zhengxiao Zhao, et al.. (2023). Predicting very early recurrence in intrahepatic cholangiocarcinoma after curative hepatectomy using machine learning radiomics based on CECT: A multi-institutional study. Computers in Biology and Medicine. 167. 107612–107612. 12 indexed citations
10.
11.
Chen, Kui, Sen Liu, Junyang Chen, et al.. (2023). Well-established immunotherapy with R837-loaded boron neutron capture-shocked tumor cells. Nano Today. 52. 101995–101995. 23 indexed citations
12.
Qiao, Jinli, Wei Jia, Jiacheng Li, et al.. (2023). C3G quantified method verification and quantified in blue honeysuckle (Lonicera caerulea L.) using HPLC–DAD. Heliyon. 9(4). e14685–e14685. 5 indexed citations
13.
Lü, Fei, Jinhuan Yang, Haitao Yu, et al.. (2023). Gut microbiome as a biomarker for predicting early recurrence of HBV‐related hepatocellular carcinoma. Cancer Science. 114(12). 4717–4731. 19 indexed citations
14.
Pang, Qingsong, Wencheng Zhang, Tian Zhang, et al.. (2023). Co-occurrence of mutations and related signal pathway analysis of CCND1 amplification in esophageal squamous cell cancer.. Journal of Clinical Oncology. 41(16_suppl). e16044–e16044.
15.
16.
Wang, Yang, Tao Liu, Jiaqi Liu, et al.. (2023). The novel compound heterozygous variants identified in a Chinese family with glucose phosphate isomerase deficiency and pathogenicity analysis. BMC Medical Genomics. 16(1). 162–162. 1 indexed citations
17.
Li, Jiacheng, Xiaozhen Liu, Lin Chen, et al.. (2023). Isopimaric acid, an ion channel regulator, regulates calcium and oxidative phosphorylation pathways to inhibit breast cancer proliferation and metastasis. Toxicology and Applied Pharmacology. 462. 116415–116415. 8 indexed citations
18.
Li, Jiacheng, Yu Xia, Biying Sun, et al.. (2023). Neutrophil extracellular traps induced by the hypoxic microenvironment in gastric cancer augment tumour growth. Cell Communication and Signaling. 21(1). 86–86. 50 indexed citations
19.
Chen, Ziyan, Jungang Zhao, Jiacheng Li, et al.. (2022). Brusatol suppresses the growth of intrahepatic cholangiocarcinoma by PI3K/Akt pathway. Phytomedicine. 104. 154323–154323. 9 indexed citations
20.
Li, Jiacheng, et al.. (2022). CRISPR-CasRx knock-in mice for RNA degradation. Science China Life Sciences. 65(11). 2248–2256. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xin Miao Breakdown of academic impact, for papers by Chuan Liu Breakdown of academic impact, for papers by Xinxin Ren Breakdown of academic impact, for papers by Lianfeng Zhang Breakdown of academic impact, for papers by Yidong Liu Breakdown of academic impact, for papers by Li‐Yuan Bai Breakdown of academic impact, for papers by Tomokazu Nagao Breakdown of academic impact, for papers by Paul Wong Breakdown of academic impact, for papers by Mohammad Azhar Aziz
Rankless by CCL
2026